CHAIN Biotechnology

About:

CHAIN Biotechnology is a microbiome therapeutics company with a novel drug development platform targeting chronic gut-related diseases.

Website: http://chainbiotech.com/

Twitter/X: CHAINBiotech

Top Investors: Innovate UK, Business Growth Fund, Future Planet Capital, UK Innovation & Science Seed Fund, SynBioVen

Description:

CHAIN Biotechnology is a microbiome therapeutics company with a novel drug development platform targeting chronic gut-related diseases. CHAIN is developing several therapeutic compounds targeted to the gut microbiome in the large intestine that can be delivered by our CADD technology.

Total Funding Amount:

2.3M GBP

Estimated Revenue Range:

Less than $1M

Headquarters Location:

Marlow, Buckinghamshire, United Kingdom

Founded Date:

2014-01-01

Contact Email:

info(AT)chainbiotech.com

Founders:

Basil Omar, Edward Green

Number of Employees:

11-50

Last Funding Date:

2023-07-26

IPO Status:

Private

Industries:

© 2025 bioDAO.ai